Martin Kim

MrVI is a deep generative model that identifies sample-level stratifications and cellular differences without prior cell-type grouping, applied to COVID-19 and IBD data.

CytoVI is a deep generative model for antibody-based single cell technologies that improves integration, imputation, and analysis across different platforms and antibody panels.

Scvi-hub provides a platform for sharing and analyzing single-cell omics datasets using pre-trained models, enabling efficient tasks like visualization and annotation with reduced computational demands.